Status:

COMPLETED

To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

Lead Sponsor:

Jiaxing AnDiCon Biotech Co.,Ltd

Conditions:

Influenza Type A

Influenza Type B

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

Brief Summary

This study aims to evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of ADC189 in subjects with hepatic impairment compared with subjects with normal hepatic function.

Detailed Description

The evaluation of ADC189/ADC189-I07 in mild hepatic insufficiency (Child-Pugh A), moderate hepatic insufficiency (Child-Pugh B) the pharmacokinetic characteristics in subjects, compared with normal li...

Eligibility Criteria

Inclusion

  • 1\) The subjects fully understand the purpose and requirements of this trial, voluntarily participate in the clinical trial and sign a written informed consent, and can complete the entire trial process according to the requirements of the trial.
  • 2\) Age 18-75 years old (including the boundary value), both male and female.
  • 3\) The body weight of male subjects was ≥50 kg, the body weight of female subjects was ≥45 kg, and the body mass index (BMI) was within the range of 18.0\~30.0 kg/m².

Exclusion

  • 1\) Known allergic history to test drug components, or allergic constitution, or history of allergic diseases.
  • 2\) Have malignant tumors, or have a history of malignant tumors within 5 years prior to screening.
  • 3\) Patients with severe infection, trauma, gastrointestinal surgery or other major surgical operations within 4 weeks before screening.
  • 4\) eGFR (CKD-EPI Cr) \<60mL/min/1.73m2.

Key Trial Info

Start Date :

March 14 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 21 2024

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT06485401

Start Date

March 14 2024

End Date

June 21 2024

Last Update

January 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Soochow University

Suzhou, China